Skip to main content
. 2024 Feb 15;13(2):187. doi: 10.3390/antibiotics13020187

Table 3.

Distinguishing between phenotypes in patients with severe septic shock due, based on identifiable treatable traits.

Precision Medicine Strategies Target (s) Clinical Application
Hyperinflammatory profile High endotoxinemia Endotoxinemia Rescue therapy Hemoadsorption
Severe hypercytokinemia Cytokine levels
Sequential hemoadsorption Endotoxin and cytokine hemoadsorption
Low perfusion phenotype Patients with septic cardiomyopathy ECMO venoarterial
Low immunoglobulin phenotype Sepsis-associated hypogammaglobulinemia250 mg/kg/d by a 10 h infusion for 3 consecutive days